Navigation Links
Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
Date:2/6/2008

Effort is Launched With UC Davis Collaboration

RANCHO CORDOVA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury, today announced a regenerative medicine initiative in the veterinary market.

The Company has created a wholly-owned subsidiary, Vantus, Inc., a veterinary stem cell laboratory services company. The Company is in the process of completing a research collaboration with the Center for Equine Health and Stem Cell Regenerative Medicine Group at the University of California, Davis, School of Veterinary Medicine.

Under the collaboration, the Company's MarrowXpress(TM) System and BioArchive(R) System will be used for the processing and cryogenic storage of equine stem cells from cell rich sources, including fetal tissue and fluids during foaling, and bone marrow from yearlings and adults. The stem cells will be used in therapeutic treatment of orthopedic injuries in the performance equine market including Thoroughbreds, American Quarter Horses, and Arabians. The Company is currently refining collection and processing methodologies at large breeder farms in California, and expects to be in operation commencing with the 2009 foaling season, which begins in January of next year.

"The creation of Vantus, Inc. is a major milestone in our regenerative medicine diversification strategy that we began implementing several months ago. This program leverages the expertise and world renowned reputation of the UC Davis organization in animal research and our industry leading stem cell processing and storage technologies," noted Dr. William Osgood, Chief
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ThermoGenesis Corp. Reports First Quarter 2008 Results
2. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
3. Zipfizz(R) Announces Expanded Distribution
4. Mangrove Announces Health Savings Account (HSA) and Health Reimbursement Account (HRA) Product Launches
5. Senetek PLC Announces Launch of New Website
6. Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
7. Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008
8. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
9. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
10. The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
11. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...ire/ -- Speaker Nancy Pelosi and Democratic leader...age of H.R. 3962, the Affordable Health Care for A...15. Below are the Speaker,s opening remarks: ,...ll from the President of the United States, Barack...he American people. I thank the President for his ...
(Date:11/8/2009)...s is pleased to announce that it has been successf...ound who recently received an award on the $800 mi...ncludes not only the Veterans Administration, but ...gencies. , New York, NY (...pleased to announce that it has been successful in...
(Date:11/8/2009)... in the Western District of Pennsylvania award a F...ng for a medical malpractice case. Attorneys Thom...mas E. Crenney and Associates, LLC handled the cas... against the Uniontown Hospital. The woman had to... age 18. , Pittsburgh, PA...
(Date:11/8/2009)...health advocates committed to achieving meaningful.... 7 "Tonight the U.S. H... voice of America,s families by passing the Afford...ust deliver, without delay, on the promise of mean...do, President and CEO of the National Alliance for...
(Date:11/8/2009)...to Secure the Stability of Medicare ,, HOUSTON...ibutable to: J. James Rohack, M.D., President, Ame...ww.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...h reform bill, which will help improve the health ...wift passage of H.R. 3961 to secure the stability ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
... ‘present’ - the common cause of amnesia, also pre...ing them to live only in the present. Researc...f Proceedings of the National Academy of Sciences ...rucial in learning and memory. Though, it has...
...bout having a child, it’s a research they will bac...ospital plan the first uterus transplant with the ...medical adventure is not without ethical controve...ient gives birth so she would not need anti-reject...
...alia health providers is busy counting its losses....ve had their doctors resort to rorting or over ser...procedures that were not necessary. The loss in...s at inappropriate practices such as over-servicin...
...rge family may not be best for your health. A new ...e development of stomach cancer linked to the bact...from large families appeared to be especially vuln...re followed over a 28-year period. The researchers...
...d a structural protein called nestin to a particul...ew biomarker that could lead to earlier detection ...sue of Cancer Research, researchers from Dartmouth...ith similarities to mammary stem cells, the regene...
...ening of adults age 50 or older appears to be as c...er screening programs, according to an article in ... Melanoma is the only cancer for which incidence...cle. Treating melanoma costs more than $740 millio...
Other Medicine News:Health News:Amnesia Halts Future Thinking: Study 2Health News:Uterus Transplant- A Future Reality 2Health News:Link Between Family Size and Stomach Cancer Found 2Health News:Link Between Family Size and Stomach Cancer Found 3Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 2Health News:Selective Marker Found to Indicate Aggressive Form of Breast Cancer 3Health News:One-time Melanoma Screening Appears to Be Cost-effective for Elderly People 2
(Date:11/6/2009)...re/ -- Facet Solutions, Inc. announced today that ...edics. The acquisition creates an undisputed leade...property and clinical experience in posterior moti...ring from lumbar spinal stenosis," stated Facet So...consolidation further strengthens Facet Solutions,...
(Date:11/6/2009)...re/ -- Philips Respironics applauds the efforts of...DC) to raise awareness about an important public h...C,s release of the first-ever government study to ...s is a milestone in quantifying the size and scope...ndustry leader and sleep therapy manufacturer, Phi...
(Date:11/6/2009)... 6 Chimerix, Inc., a biopharmaceut...therapeutics to address life-threatening diseases,...ny,s lead antiviral compound, CMX001, to the World...ecurity Initiative (GHSI). CMX001 is a broad-spec...ment of smallpox, as well as other serious viral i...
Breaking Medicine Technology:Facet Solutions Acquires Archus Orthopedics 2Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 1Nektar Therapeutics to Present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York City 13311 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 1Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 2Partnership for Prescription Assistance Prepared to Help New York Workers Hurt by Recession 53371 3
...ed Alone and in Combination with Chemotherapy, FR..., a,development-stage pharmaceutical company disco...)-based therapeutics, today announced that the,jou... of siRNA targeting,its proprietary target gene ag...ition dated October 1, 2008. The paper, entitled "...
...ASHINGTON, Oct. 12 Boston,Scientific Corporation ...ysis,of nearly 7,500 patients from its TAXUS ARRIV...m the performance of the TAXUS(R) Express2(TM),Pac...d practice. The,two-year pooled ARRIVE data showed...in patients with diabetes as effectively as in pat...
Other Medicine Technology:Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5
OHL Periosteal Elevator
Steinhauser Periosteal Elevator
Dolwick-Reich Condyle Periosteal Elevator
Molt Periosteal Elevator
Medicine Products: